全球生物成像市場（按成像方式、最終用戶和地區分類）

2025 年全球生物成像市場價值估計為 80.7 億美元，預計到 2032 年將達到 221.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 15.5%。

數字。 2025年全球市場佔有率（按地區）

生物成像是一項強大而重要的技術，廣泛應用於生物學和醫學領域。它是指從分子層次到器官層次獲取、處理和可視化生物系統結構和功能資訊的技術集合。生物影像的主要目標是更深入地了解複雜的生物過程，促進準確的醫學診斷，並指南介入和治療。生物影像利用多種技術，包括X光、磁振造影（MRI）、正子斷層掃描（PET）、超音波和光學顯微鏡，為了解生物體內部運作提供了一個非侵入性的窗口。它們使研究人員和臨床醫生能夠即時觀察細胞和組織內的複雜相互作用，為現代診斷和疾病機制研究奠定了基石。最近的進展將生物成像的前沿擴展到奈米級，從而能夠即時追蹤細胞和分子事件。超高解析度顯微鏡、光聲成像和生物發光等技術正在揭示前所未有的細節，並提高我們對與健康和疾病相關的生物途徑的理解。生物成像從根本上來說是一個跨學科領域，涵蓋物理學、工程學、生物學、化學、電腦科學和醫學。它需要整合高解析度成像設備、先進的影像分析軟體以及對底層生物過程的深入了解。在應用中，生物成像對於實驗室和醫療保健環境至關重要。它有助於早期發現疾病，提高手術精度，並有助於開發標靶藥物療法。隨著成像技術的不斷發展，它有望透過考慮到每個患者個體生物學特徵的客製化治療方法徹底改變個人化醫療。因此，生物成像處於科學進步的前沿，彌合了基礎研究與臨床應用之間的差距，並推動了未來醫療保健創新的發展。

市場動態：

預計全球生物成像市場將在預測期內出現強勁成長，這歸因於老年人口增加、慢性病和文明病患病率增加、診斷成像方式的技術進步以及醫療保健支出增加等因素。然而，與生物成像系統、程序和放射性示踪劑相關的高成本仍然是一個重大挑戰。此外，有關輻射暴露的多項指導方針和法規也限制了市場。然而，新興國家尚未開發的商業機會很可能在不久的將來為市場相關人員開闢新的途徑。

本研究的主要特點

• 本報告對全球生物成像市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球生物成像市場的主要企業概況。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球生物成像市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員將透過用於分析全球生物成像市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
• 成像技術的進展
  • 限制因素
• 高資本投資要求
  • 機會
• 混合成像系統
• 主要亮點
• 監管情景
• 近期動態
• PEST分析
• 波特分析
• 合併、收購和合作

第4章全球生物影像市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020 年至 2032 年全球生物影像市場（依影像方式分類）

• 磁振造影（MRI）
• 電腦斷層掃描（CT）
• 正子斷層掃描（PET）
• 超音波
• X光
• 其他

6. 2020 年至 2032 年全球生物影像市場（依最終用戶分類）

• 醫院和診斷中心
• 學術研究所
• 製藥和生物技術公司
• 其他

7. 2020-2032 年全球生物影像市場（按地區）

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第8章 競爭態勢

• 公司簡介
  • Bracco Imaging SPA
  • Bayer HealthCare Pharmaceuticals
  • Esaote SpA
  • Digirad Corporation
  • FONAR Corporation
  • GE Healthcare
  • Hologic Inc
  • Hitachi Medical Corporation
  • Lantheus Medical Imaging, Inc.
  • Covidien Pharmaceuticals
  • Mindray Medical International Limited.
  • Gamma Medica Inc
  • Samsung Medison Co., Ltd.
  • Philips Healthcare

第9章 章節

• 參考
• 調查方法
• 關於出版商

Global Bio-imaging Market is estimated to be valued at USD 8.07 Bn in 2025 and is expected to reach USD 22.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.5% from 2025 to 2032.

Figure. Global Bio-imaging Market Share (%), By Region 2025

Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.

Market Dynamics:

Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.

Key features of the study:

• This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market

Detailed Segmentation:

• Global Bio-imaging Market Segmentation, By Imaging Modality:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Position Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Others
• Global Bio-imaging Market Segmentation, By End User:
  • Hospitals & diagnostic centers
  • Academic & research institutes
  • Pharmaceutical & biotech companies
  • Others
• Global Bio-imaging Market Segmentation, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Bracco Imaging S.P.A
  • Bayer HealthCare Pharmaceuticals
  • Esaote S.p.A
  • Digirad Corporation
  • FONAR Corporation
  • GE Healthcare
  • Hologic Inc
  • Hitachi Medical Corporation
  • Lantheus Medical Imaging, Inc.
  • Covidien Pharmaceuticals
  • Mindray Medical International Limited.
  • Gamma Medica Inc
  • Samsung Medison Co., Ltd.
  • Philips Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Bio-imaging, By Imaging Modality
  • Market Bio-imaging, By End User
  • Market Bio-imaging, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Technological advancements in bio-imaging modalities
  • Restraints
• High capital investment requirements
  • Opportunities
• Hybrid imaging systems
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Bio-imaging Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Bio-imaging Market, By Imaging Modality, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Position Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Ultrasound
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• X-ray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Bio-imaging Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & diagnostic centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic & research institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Pharmaceutical & biotech companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Bio-imaging Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

• Company Profile
  • Bracco Imaging S.P.A
• Company Highlights
• Imaging Modality Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Bayer HealthCare Pharmaceuticals
  • Esaote S.p.A
  • Digirad Corporation
  • FONAR Corporation
  • GE Healthcare
  • Hologic Inc
  • Hitachi Medical Corporation
  • Lantheus Medical Imaging, Inc.
  • Covidien Pharmaceuticals
  • Mindray Medical International Limited.
  • Gamma Medica Inc
  • Samsung Medison Co., Ltd.
  • Philips Healthcare
• Analyst Views

9. Section

• References
• Research Methodology
• About us